Actualités sur Enterprises

Suivre
Abonner Enterprises
Filtre
  • 07.05.2009 – 14:08

    Wyeth Pharmaceuticals

    FDA Grants Priority Review Status to Prevnar 13 Marketing Application

    Collegeville, Pennsylvania (ots/PRNewswire) - -- Candidate vaccine designed to protect against the 13 most prevalent serotypes associated with pneumococcal disease -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced today that the U.S. Food and Drug Administration (FDA) granted priority review to the company's Biologic License Application ...

  • 07.05.2009 – 07:07

    Amsterdam Molecular Therapeutics B.V

    AMT Starts Preregistration Trial for Glybera(TM)

    Amsterdam (ots/PRNewswire) - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today the treatment of the first patient in a preregistration clinical trial with Glybera(TM). This gene therapy product targets lipoprotein lipase deficiency (LPLD), a seriously debilitating and potentially lethal disease. The randomized controlled trial has been designed to ...

  • 06.05.2009 – 04:35

    Mechtronix Systems Inc.

    Pegasus Airlines Logs 3,000 Hours FFS Time at IFTC Istanbul

    Montreal (ots/PRNewswire) - - Taking Advantage of the Train at Home Concept, Pegasus Airlines Trains at IFTC Istanbul and Becomes IFTC's First Golden Airline Mileage Customer in Less than a Year IFTC Istanbul, the training arm of the Gozen Holding, today announced that Pegasus Airlines has reached 3,000 hours of simulator training time making the Turkish airline the largest customer of IFTC. The ...

  • 04.05.2009 – 07:05

    ODS-Petrodata

    Cost of Field Development Projects to Decline 12-13 Percent Year-On-Year in 2009

    Oslo (ots/PRNewswire) - ODS-Petrodata has recently revised its MSS Cost Index for field development projects based on a worsening outlook for the global economy, commodity prices and contractor margins. Global field development and pipeline construction investment, not including drilling, is expected to decline by 15 percent in 2009 relative to 2008, ...